PRESS RELEASE published on 11/28/2023 at 15:00, 2 years 6 months ago Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter Wellness
PRESS RELEASE published on 11/27/2023 at 13:30, 2 years 6 months ago FSD Pharma Inc. Obtains Final Order for Plan of Arrangement
PRESS RELEASE published on 11/21/2023 at 14:45, 2 years 7 months ago FSD Pharma Inc. Securityholders Approve Plan of Arrangement with Celly Nutrition Corp.
PRESS RELEASE published on 11/17/2023 at 14:00, 2 years 7 months ago FSD Pharma Announces Distribution Date for Distribution of Celly Shares Pursuant to Plan of Arrangement
PRESS RELEASE published on 11/15/2023 at 15:00, 2 years 7 months ago FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023
PRESS RELEASE published on 11/07/2023 at 17:45, 2 years 7 months ago FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basis
PRESS RELEASE published on 10/23/2023 at 15:00, 2 years 7 months ago FSD Pharma Files Management Information Circular for Proposed Arrangement with Celly Nu
PRESS RELEASE published on 10/05/2023 at 13:30, 2 years 8 months ago FSD Pharma and Celly Nu Enter Into Arrangement Agreement
PRESS RELEASE published on 10/04/2023 at 14:30, 2 years 8 months ago FSD Pharma Wins $2.8 Million Dollar Award Plus Accruing Interest from Dr. Raza Bokhari; Set Aside Motion Brought by Bokhari, Now CEO of Medicus Pharma, Dismissed by the Ontario Superior Court of Justice
PRESS RELEASE published on 09/18/2023 at 13:30, 2 years 9 months ago FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated
Published on 06/20/2026 at 01:00, 2 days 4 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 5 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 4 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/22/2026 at 04:05, 1 hour 18 minutes ago Optro Accelerates Global Growth with Singapore Hub, Delivering Agentic GRC to APAC Enterprises
Published on 06/20/2026 at 21:25, 1 day 7 hours ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 23 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 9 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 2 days 9 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:33, 2 days 9 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 9 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 10 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 10 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
